Abstract:Highlights • The solubility and cumulative release of microspheres were improved by spray drying. • The coating microspheres were prepared by emulsification–solvent evaporation method to achieve the goal of slow release. • The coated microspheres were prepared into coated microspheres gels, which could avoid the first-pass effect of liver and gastrointestinal tract. • The DMP coated microspheres gels were successfully prepared. • The problems encountered in traditional oral administration of DMP were improved. • The bioavailability of the DMP coated microsphere gel group was 3.2 times that of the oral administration group. Domperidone (DMP) is an effective peripheral D2 dopamine receptor antagonist. It is commonly used in the treatment of nausea and vomiting caused by Parkinson's disease. An oral preparation, which is rapidly absorbed after administration, and reaches a peak plasma concentration within 15–30 min, is commonly used. However, owing to the "first-pass effect" of liver metabolism and intestinal wall metabolism, the oral bioavailability of domperidone is low, and the action period is long. Therefore, in the present study, spray drying and emulsion solvent evaporation were combined to prepare a coated microsphere preparation with sustained release effect, and a gel matrix was selected to prepare a sustained-release coated microsphere gel for transdermal drug delivery. The pharmacokinetic results showed that the transdermal sustained-release coated microsphere gel effectively increased the Tmax, Cmax, T 1/2 , and AUC compared with those of an oral DMP group ( P < 0.05), and the relative bioavailability was 3.2 times that of the oral DMP group. This indicates that the preparation was able to ameliorate the problems associated with a traditional oral DMP formulation. Therefore, the present study may provide a theoretical basis for the transdermal delivery of DMP sustained-release microspheres. Graphical abstract Download : Download high-res image (176KB) Download : Download full-size image

Clinical application and cardiotoxicity of domperidone

Retrospective analysis of cardiac adverse reactions induced by domperidone

Association Between Polymorphism of Dopamine D2 Receptor Genes and Therapeutic Effect of Domperidone in Functional Dyspepsia.

Systematic Review of Domperidone in Clinical Practice

Cardiac Arrhythmias during Cytotoxic Chemotherapy: Role of Domperidone

Treatment of functional dyspepsia in Chinese adult patients with domperidone: A multicenter, randomized, double-blind, placebo-controlled pilot study

Effect of relative bioavailability of domperidone maleate combined with antacids in healthy volunteers

Four-Way Crossover Phase 1 Thorough QT Study to Assess Cardiac Safety of Domperidone and Consideration for Design and Conduct of QT/QTc Study in China

Pharmacokinetics of Domperidone Tablets in Chinese Healthy Volunteers

[Cardiotoxicity of drugs used in oncology]

Domperidone, a Dopamine Receptor D2 Antagonist, Induces Apoptosis by Inhibiting the ERK/STAT3-Mediated Pathway in Human Colon Cancer HCT116 Cells

Transdermal drug delivery system of domperidone sustained-release coated microsphere gels: In vitro characterization and in vivo evaluation

A Novel Domperidone Hydrogel: Preparation, Characterization, Pharmacokinetic, and Pharmacodynamic Properties

Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance

Hyperprolactinemia in Functional Dyspepsia: The Entangled Domperidone Link

Pharmacokinetics and Bioequivalence of Domperidone Chewable Tablets in Healthy Volunteers

Clinical Efficacy of Amitriptyline Combined with Domperidone in the Treatment of Functional Dyspepsia

Study on the Preparation and Characteristics of Domperidone Gel

Investigation of the Reverse Effect of Danhong Injection on Doxorubicin-Induced Cardiotoxicity in H9c2 Cells: Insight by LC–MS Based Non-Targeted Metabolomic Analysis

Bioequivalence of domperidone tablets in Chinese healthy volunteers after a single oral administration

Can Domperidone Decrease Transit Time of Pediatric Video Capsule Endoscopy? A Randomized Controlled Trial